Is Amrutanjan Health Care a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amrutanjan Health Care Ltd is a good quality company .

Is Amrutanjan Health Care undervalued or overvalued?

The key valuation ratios of Amrutanjan Health Care Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Amrutanjan Health Care share price return in the past 10 years?

Amrutanjan Health Care Ltd share price has appreciated 25.4% annually (CAGR) over the past ten years.

Is Amrutanjan Health Care a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Amrutanjan Health Care Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the P/E ratio of Amrutanjan Health Care?

The latest standalone P/E ratio of Amrutanjan Health Care as of 23-Apr-2024 is 44.73.

What is the P/B ratio of Amrutanjan Health Care?

The latest standalone P/B ratio of Amrutanjan Health Care as of 23-Apr-2024 is 7.04.

Amrutanjan Health Care Ltd - Stock Valuation and Financial Performance

Name: Amrutanjan Health Care
Brand: Amrutanjan Health Care

BSE: 590006 | NSE: AMRUTANJAN | Pharmaceuticals & Drugs | Small Cap

Place order

Amrutanjan Healthcar Share Price

₹673.05 -7.85 -1.15%
as on 23-Apr'24 15:40

10 Year X-Ray of Amrutanjan Healthcar:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	16.1%	16.9%	19.5%	18.7%	15.3%	18%	16.5%	32.9%	28.1%	14.4%	-
Value Creation Index ⓘ	0.2	0.2	0.4	0.3	0.1	0.3	0.2	1.4	1.0	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	139	163	184	212	220	253	261	333	406	380	394
Sales YoY Gr.	-	17.6%	12.9%	14.8%	4%	15.2%	3.2%	27.3%	21.9%	-6.5%	-
Adj EPS ⓘ	5.2	5.9	7.5	7.5	6.4	8.4	8.6	20.9	23	13.6	15.2
YoY Gr.	-	13.2%	27.9%	0.3%	-14.9%	31.4%	2%	144.9%	9.8%	-40.8%	-
BVPS (₹) ⓘ	33.2	35.9	41.2	39.6	44	49.9	54.5	73.5	90.5	99.1	96.7
Adj Net Profit ⓘ	15.1	17.1	21.9	21.9	18.7	24.5	25	61.2	67.2	39.8	44
Cash Flow from Ops. ⓘ	17.6	18.8	21.4	8.3	19.1	21.2	18.2	90.9	52.2	20.2	-
Debt/CF from Ops. ⓘ	0.3	0	0	0.3	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	11.8%	11.5%	13.2%	-6.5%
Adj EPS ⓘ	11.4%	16.4%	16.8%	-40.8%
BVPSⓘ	12.9%	17.6%	22%	9.5%
Share Price	25.4%	17.3%	2%	10%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	16.4	16.9	19.4	18.6	15.3	17.9	16.4	32.7	28	14.3	15.6
Op. Profit Mgn % ⓘ	16.8	15.1	17.1	14.2	12.9	12.2	11.8	20.3	19.1	11.8	12.3
Net Profit Mgn % ⓘ	10.9	10.5	11.9	10.4	8.5	9.7	9.6	18.4	16.6	10.5	11.2
Debt to Equity ⓘ	0.1	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	155	130	123	122	111	81	125	115	130	208	121
Cash Conv. Cycle ⓘ	56	49	43	24	12	14	19	-7	-12	0	87

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 13.23%

Net Profit is growing at healthy rate in last 3 years 16.76%

Return on Equity has declined versus last 3 years average to 15.50%

Sales growth is not so good in last 4 quarters at 3.35%

Latest Financials - Amrutanjan Health Care Ltd.

	Standalone	Consolidated
TTM EPS (₹)	15.2	7.3
TTM Sales (₹ Cr.)	394	232
BVPS (₹.) ⓘ	96.7	0
Reserves (₹ Cr.) ⓘ	277	106
P/BV ⓘ	7.04	0.00
PE ⓘ	44.73	93.11

From the Market
52 Week Low / High (₹)	556.05 / 774.75
All Time Low / High (₹)	5.05 / 1025.55
Market Cap (₹ Cr.)	1,969
Equity (₹ Cr.)	2.9
Face Value (₹)	1
Industry PE ⓘ	47.9

Management X-Ray of Amrutanjan Healthcar:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Amrutanjan Healthcar

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Amrutanjan Healthcar

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	139	163	184	212	220	253	261	333	406	380
Operating Expenses ⓘ	116	139	153	182	192	222	231	266	328	335
Manufacturing Costs	31	36	37	7	17	16	17	18	29	34
Material Costs	29	32	37	87	96	119	117	140	180	182
Employee Cost	22	25	28	30	34	33	39	42	48	49
Other Costs ⓘ	34	46	51	57	45	54	57	66	71	71
Operating Profit ⓘ	22	25	32	30	28	31	31	67	78	45
Operating Profit Margin (%)	16.1%	15.1%	17.1%	14.1%	12.9%	12.2%	11.8%	20.2%	19.1%	11.7%
Other Income ⓘ	4	5	6	7	8	7	8	19	17	15
Interest ⓘ	2	1	0	1	0	0	0	1	1	0
Depreciation ⓘ	3	2	3	3	3	3	4	4	4	5
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	21	26	35	34	33	35	34	82	91	54
Tax ⓘ	7	9	12	12	13	10	9	21	23	14
Profit After Tax	15	17	22	22	20	25	25	61	67	40
PAT Margin (%)	10.5%	10.5%	12.2%	10.3%	9.1%	9.7%	9.6%	18.4%	16.6%	10.5%
Adjusted EPS (₹)	5.0	5.9	7.7	7.5	6.9	8.4	8.6	20.9	23.0	13.6
Dividend Payout Ratio (%)	32%	30%	25%	26%	28%	26%	24%	20%	20%	34%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	97	105	120	116	129	146	159	215	265	290
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	94	102	118	113	126	143	157	212	262	287
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	6	0	0	2	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	6	0	0	2	0	0	0	0	0	0
Trade Payables	7	7	9	25	26	30	31	41	60	47
Others Liabilities ⓘ	15	18	19	5	7	8	10	15	21	21
Total Liabilities ⓘ	124	130	149	149	162	183	201	271	346	358
Fixed Assets
Gross Block	32	26	39	30	33	35	39	39	48	74
Accumulated Depreciation	18	13	16	3	6	9	13	16	19	25
Net Fixed Assetsⓘ	15	13	22	27	28	26	26	23	28	49
CWIP ⓘ	1	4	1	1	0	0	0	2	17	1
Investmentsⓘ	14	14	10	10	8	18	18	18	13	5
Inventories	7	7	8	10	10	15	24	17	26	29
Trade Receivables	24	26	26	29	28	33	26	18	38	33
Cash Equivalents	35	38	48	31	73	81	36	139	88	70
Others Assetsⓘ	29	29	34	42	16	11	70	54	136	170
Total Assets ⓘ	124	130	149	149	162	183	201	271	346	358

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	18	19	21	8	19	21	18	91	52	20
PBT ⓘ	21	26	35	34	33	35	34	82	91	54
Adjustment ⓘ	3	-1	-2	0	-4	-3	-1	-3	-10	-8
Changes in Working Capital ⓘ	1	3	1	-11	0	-1	-4	31	-4	-10
Tax Paid ⓘ	-7	-9	-11	-14	-11	-10	-11	-19	-24	-16
Cash Flow From Investing Activity ⓘ	16	-5	1	0	-8	-11	-14	-88	-36	-2
Capex	-1	-6	-1	-4	-1	-2	-3	-2	-23	-9
Net Investments	15	0	0	-1	-13	-14	-17	-92	-25	-5
Others ⓘ	2	0	3	4	6	5	6	6	13	11
Cash Flow From Financing Activityⓘ	-14	-12	-11	-5	-9	-7	-12	-7	-17	-15
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-2	0	0	-1	0	0	0	0	0	0
Dividend Paid ⓘ	-5	-6	-11	-4	-6	-6	-9	-6	-12	-14
Others ⓘ	-7	-6	0	0	-4	-1	-2	-2	-4	-1
Net Cash Flow ⓘ	20	2	12	3	2	3	-7	-4	-1	3

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	15.72	16.97	19.9	18.46	16.41	17.87	16.44	32.69	28.03	14.37
ROCE (%)	22.63	26.06	30.86	28.65	26.95	25.43	22.8	44	37.93	19.38
Asset Turnover Ratio	1.16	1.35	1.39	1.49	1.42	1.47	1.36	1.41	1.32	1.08
PAT to CFO Conversion(x)	1.2	1.12	0.95	0.36	0.95	0.84	0.72	1.49	0.78	0.5
Working Capital Days
Receivable Days	64	53	50	45	47	44	41	24	25	34
Inventory Days	17	15	14	15	17	18	27	23	20	26
Payable Days	96	79	81	72	98	86	95	94	102	108

Amrutanjan Health Care Ltd Stock News

Amrutanjan Health Care Ltd FAQs

What is the share price of Amrutanjan Healthcar?

Company share prices are keep on changing according to the market conditions. The closing price of Amrutanjan Healthcar on 23-Apr-2024 15:40 is ₹673.0.

What is the market cap of Amrutanjan Healthcar?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Apr-2024 15:40 the market cap of Amrutanjan Healthcar stood at ₹1,968.5.

What is the P/E ratio of Amrutanjan Healthcar?

The latest P/E ratio of Amrutanjan Healthcar as of 23-Apr-2024 15:40 is 44.73.

What is the P/B ratio of Amrutanjan Healthcar?

The latest P/B ratio of Amrutanjan Healthcar as of 23-Apr-2024 15:40 is 7.04.

What is the 52-week high and low of Amrutanjan Healthcar?

The 52-week high of Amrutanjan Healthcar is ₹774.8 and the 52-week low is ₹556.0.

What is the TTM revenue of Amrutanjan Healthcar?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amrutanjan Healthcar is ₹394.5 ( Cr.) .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care was started in the year 1893 by social reformer, journalist and freedom fighter, Nageswara Rao Pantulu Garu. Today Amrutanjan is one of the household names in South India.

While Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company with a rich heritage of over 100 years, the company is also planning to introduce a series of next generation products in healthcare category.

With a wide range of ayurvedic and allopathic products, Amrutanjan has helped millions of people relieve themselves from the pain and discomfort of headaches, colds, sprains, muscular pains, rheumatic pains and stands a real pain management specialist for its loyal customers.

The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai. Apart from the products in the pain care segment, other categories include cough and cold care, health and home care.

Its products are available in the Gulf, African, South East and Asian countries. Plans are ready to enter the US and European markets in a big way.

Products